Stocks · Health care · Pharmaceutical Preparations

Septerna, Inc.

SEPN Clue Score47

United States Fiscal year ends December CIK 0001984086 Results filed 10 Aug 2026

Add to watchlist

What the insiders did Net buying

By person

10 insiders · 53 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ra Capital Management, L.p. entity

Director

$75.06M (2)

$63.45M (2)

+$11.61M

725,443

1.55%

$27.29M

—

Third Rock Ventures VI, L.P. entity

10% owner

$6.28M (3)

—

+$6.28M

4,211,659

9.02%

$158.42M

+33.6%

Third Rock Ventures V, L.P. entity

10% owner

$11.70M (2)

$7.40M (2) scheduled

+$4.30M

9,220,847

19.75%

$346.83M

+1,113%

Samira Shaikhly

Chief People Officer

—

$2.80M (8) scheduled

−$2.80M

793

0.0017%

$29.83K

0.0%

Elizabeth Bhatt

President and COO

—

$1.60M (9) scheduled

−$1.60M

174,209

0.3732%

$6.55M

0.0%

Daniel D. Long

SVP, Drug Discovery

—

$951.33K (8) scheduled

−$951.33K

96,412

0.2066%

$3.63M

−3.5%

Alan Ezekowitz

Director

$608.20K (4)

—

+$608.20K

117,420

0.2516%

$4.42M

+574.1%

Gil M Labrucherie

Chief Financial Officer

$229.16K (5)

—

+$229.16K

40,000

0.0857%

$1.50M

—

Jeffrey Finer

Chief Executive Officer

$96.96K (3)

—

+$96.96K

826,907

1.77%

$31.10M

+9.5%

Uwe Klein

SVP, Biological Sciences

—

—

—

23,008

0.0493%

$865.43K

—